Chemed Corporation
CHE · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 2.40 | 3.88 | -12.46 | -2.15 |
| FCF Yield | 4.62% | 3.11% | 3.31% | 3.01% |
| EV / EBITDA | 17.06 | 20.98 | 19.81 | 20.87 |
| Quality | ||||
| ROIC | 19.44% | 18.78% | 21.88% | 24.39% |
| Gross Margin | 35.14% | 35.28% | 35.84% | 35.98% |
| Cash Conversion Ratio | 1.38 | 1.21 | 1.24 | 1.15 |
| Growth | ||||
| Revenue 3-Year CAGR | 4.43% | 1.91% | 0.88% | 3.34% |
| Free Cash Flow Growth | 34.57% | 8.27% | 1.06% | -41.94% |
| Safety | ||||
| Net Debt / EBITDA | -0.08 | -0.26 | 0.44 | 0.71 |
| Interest Coverage | 205.89 | 109.58 | 74.93 | 183.64 |
| Efficiency | ||||
| Inventory Turnover | 192.47 | 122.09 | 133.36 | 135.47 |
| Cash Conversion Cycle | 17.37 | 16.30 | 15.41 | 6.64 |